Description

3-(4-Fluorophenyl)-5-Methyl-4-Isoxazolemethanol is a high-purity fluorinated isoxazole derivative, a key advanced pharmaceutical intermediate (API) and versatile building block for medicinal chemistry. Its value lies in its unique molecular scaffold, which is integral to the synthesis of novel bioactive compounds targeting a range of therapeutic areas. This compound is essential for research and development teams in the pharmaceutical, agrochemical, and fine chemical industries seeking to develop new active ingredients.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and anti-inflammatory research.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging the bioactivity of the fluorinated isoxazole moiety.
• Medicinal Chemistry: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Employed in the preparation of complex, high-value specialty chemicals for various industrial applications.
• Biochemical Research: Utilized as a probe or inhibitor in enzymatic studies due to its potential interaction with biological targets.
• Material Science Precursor: Can act as a precursor for the synthesis of functionalized materials with specific electronic or photophysical properties.

Basic Information

Product Name	3-(4-Fluorophenyl)-5-Methyl-4-Isoxazolemethanol
CAS No.	1018297-63-6
Molecular Formula	C11H10FNO2
Molecular Weight	207.20 g/mol
Synonyms	4-Isoxazolemethanol, 3-(4-fluorophenyl)-5-methyl-; 5-Methyl-3-(4-fluorophenyl)-4-isoxazolemethanol; (3-(4-Fluorophenyl)-5-methyl-1,2-oxazol-4-yl)methanol; 3-(p-Fluorophenyl)-5-methyl-4-isoxazolemethanol; 4-Hydroxymethyl-3-(4-fluorophenyl)-5-methylisoxazole; Fluorophenyl Methyl Isoxazole Methanol
EINECS	Contact for details

Quality Control

Our production of 3-(4-Fluorophenyl)-5-Methyl-4-Isoxazolemethanol adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. The material is manufactured in facilities operating under cGMP (current Good Manufacturing Practice) guidelines where applicable. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles, available upon request. Our quality systems are designed to meet the rigorous standards required for pharmaceutical R&D and commercial scale-up.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents. The container should be kept tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%, Total impurities ≤ 1.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.